Health
Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 variant – News-Medical.Net
In a recent research paper currently available on the bioRxiv* preprint server, a diverse group of researchers has examined the immunogenicity of antibodies against…
In a recent research paper currently available on the bioRxiv* preprint server, a diverse group of researchers has examined the immunogenicity of antibodies against the variant B.1.1.7 of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) initially found in the United Kingdom – and revealed diminished recognition and neutralization of either parental strains or the South African variant.
The ceaseless pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 still has a…
-
Noosa News10 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
Business22 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
-
General18 hours agoWotjobaluk Nations Festival marks landmark native title recognition
-
General23 hours agoRabbi Eli Schlanger killed in Bondi terror attack